M617-1551 Screening compound: N~8~-(3,5-difluorobenzyl)-1-oxo-2-(2-pyridylmethyl)-1,2,3,4-tetrahydropyrazino[1,2-a][1,3]benzimidazole-8-carboxamide

M617-1551 Screening compound: N~8~-(3,5-difluorobenzyl)-1-oxo-2-(2-pyridylmethyl)-1,2,3,4-tetrahydropyrazino[1,2-a][1,3]benzimidazole-8-carboxamide
M617-1551 Screening compound: N~8~-(3,5-difluorobenzyl)-1-oxo-2-(2-pyridylmethyl)-1,2,3,4-tetrahydropyrazino[1,2-a][1,3]benzimidazole-8-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound M617-1551
N~8~-(3,5-difluorobenzyl)-1-oxo-2-(2-pyridylmethyl)-1,2,3,4-tetrahydropyrazino[1,2-a][1,3]benzimidazole-8-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M617-1551

Molecular Formula

C24H19F2N5O2 (C24 H19 F2 N5 O2)

Compound Name

N~8~-(3,5-difluorobenzyl)-1-oxo-2-(2-pyridylmethyl)-1,2,3,4-tetrahydropyrazino[1,2-a][1,3]benzimidazole-8-carboxamide

IUPAC name

n/a

SMILES

O=C(c(cc1)cc2c1n(CCN(Cc1ncccc1)C1=O)c1n2)NCc1cc(F)cc(F)c1

InChI

InChI=1S/C24H19F2N5O2/c25-17-9-15(10-18(26)12-17)13-28-23(32)16-4-5-21-20(11-16)29-22-24(33)30(7-8-31(21)22)14-19-3-1-2-6-27-19/h1-6,9-12H,7-8,13-14H2,(H,28,32)

InChI Key

ZDIJSTCQKXYKBG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27549202

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

447.44

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.933

Distribution Coefficient, logD

2.932

Water Solubility, LogSw

-3.32

Polar Surface Area

60.839

Acid Dissociation Constant (pKa)

11.75

Base Dissociation Constant (pKb)

4.59

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

16.70

M617-1551 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

DGK Inhibitors Library (10558 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Mimetics
Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Proteases
Mechanism of action:
  • PPI modulators
  • PPI modulators

References: we are preparing a list of scientific research reports with M617-1551 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound M617-1551?
Check Price and Availability of M617-1551, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of M617-1551 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for M617-1551
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for M617-1551
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of M617-1551 available by request